An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00329095 |
Recruitment Status :
Completed
First Posted : May 24, 2006
Last Update Posted : May 24, 2006
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Glaucoma Ocular Hypertension | Drug: travoprost, latanoprost, or bimatoprost Drug: Additional ocular hypotensive medication | Phase 4 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 60 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | An Evaluation of Use of Topical Ocular Hypotensive Medication by Electronic Compliance Measures |
Study Start Date : | December 2005 |
Study Completion Date : | April 2006 |

- Compliance.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Currently using one or two topical ocular hypotensive medications
Exclusion Criteria:
- Hypersensitivity to any component of medication

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00329095
Principal Investigator: | Alan L. Robin, MD | Alan L. Robin, M.D. |
ClinicalTrials.gov Identifier: | NCT00329095 |
Other Study ID Numbers: |
GMED-01 |
First Posted: | May 24, 2006 Key Record Dates |
Last Update Posted: | May 24, 2006 |
Last Verified: | May 2006 |
Glaucoma Compliance |
Glaucoma Ocular Hypertension Eye Diseases Latanoprost |
Bimatoprost Travoprost Antihypertensive Agents |